SlideShare a Scribd company logo
1 of 4
With Bonus Units at Full Value Without Bonus Units
Rank MAT July -14 Jul-14 Val in Crs Rank MAT July -14 Jul-14
MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% COMPANY MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR%
78902 100 6.4 7161 100 7.2 IPM 75955 100 6.6 6897 100 7.6
1 1 4269 5.41 15.7 387 5.41 14.4 Sun Pharma 1 1 4174 5.50 14.9 381 5.52 14.8
2 2 3867 4.90 5.9 344 4.81 9.5 Cipla 2 2 3637 4.79 8.6 324 4.70 11.2
3 4 3097 3.93 5.3 269 3.75 6.3 Zydus Cadila 4 4 2908 3.83 5.2 254 3.68 6.5
4 5 3055 3.87 1.8 266 3.72 5.7 Ranbaxy 3 3 2954 3.89 1.8 257 3.73 5.5
5 3 2790 3.54 4.9 272 3.80 9.1 Mankind 8 7 2373 3.12 6.6 236 3.42 12.4
6 7 2761 3.50 -16.4 244 3.40 -9.5 Glaxo 5 6 2734 3.60 -15.5 242 3.51 -8.4
7 8 2689 3.41 -2.2 231 3.23 -4.0 Abbott HC 6 8 2605 3.43 -2.4 224 3.25 -3.5
8 6 2649 3.36 12.3 249 3.47 13.2 Lupin 7 5 2593 3.41 12.3 244 3.53 13.6
9 10 2411 3.06 7.2 220 3.08 0.3 Alkem 9 10 2247 2.96 7.7 206 2.98 1.2
10 11 2289 2.90 4.1 200 2.80 1.4 Pfizer 10 11 2238 2.95 4.4 196 2.85 1.7
11 9 2152 2.73 14.8 223 3.11 27.9 Macleods 12 9 2016 2.65 14.6 209 3.03 28.1
12 13 2043 2.59 14.4 185 2.59 12.9 Intas 11 12 2017 2.65 14.7 183 2.66 13.2
13 14 1956 2.48 -1.9 178 2.49 4.0 Sanofi India 13 13 1918 2.53 -2.1 175 2.53 3.9
14 12 1928 2.44 14.3 188 2.63 16.2 Aristo 15 15 1695 2.23 11.9 164 2.38 15.3
15 15 1744 2.21 3.0 169 2.36 12.6 Torrent 14 14 1709 2.25 3.4 165 2.40 13.0
16 17 1702 2.16 15.8 150 2.10 9.6 Glenmark 16 18 1652 2.18 15.5 146 2.11 9.3
17 16 1679 2.13 7.2 154 2.15 11.9 Dr. Reddys 17 16 1644 2.16 6.4 150 2.18 11.6
18 19 1574 1.99 11.1 145 2.03 13.0 Micro Lab 19 19 1505 1.98 11.8 139 2.01 13.6
19 18 1551 1.97 9.3 149 2.08 19.4 Abbott 18 17 1540 2.03 9.0 148 2.14 19.4
20 20 1420 1.80 21.8 133 1.85 21.2 Ipca 21 20 1353 1.78 21.9 127 1.84 22.4
21 21 1419 1.80 8.4 126 1.76 8.2 USV 20 21 1412 1.86 8.3 126 1.82 8.2
22 22 1362 1.73 21.6 124 1.73 17.5 Emcure 22 22 1334 1.76 21.7 122 1.76 17.3
23 23 1237 1.57 5.6 103 1.43 7.9 Wockhardt 23 23 1213 1.60 5.5 101 1.46 8.1
24 24 1129 1.43 -2.5 99 1.38 -2.5 Novartis 24 24 1091 1.44 -1.5 96 1.39 -0.9
25 25 1066 1.35 9.1 92 1.29 4.7 Alembic 25 25 1035 1.36 9.8 90 1.30 5.7
26 28 822 1.04 0.6 68 0.95 -11.1 Zuventus 27 28 784 1.03 0.8 65 0.95 -11.2
27 26 820 1.04 2.5 74 1.04 0.5 FDC 26 26 797 1.05 2.3 72 1.04 0.2
28 27 798 1.01 8.3 72 1.00 13.1 Unichem 28 27 781 1.03 7.7 70 1.02 13.1
29 29 693 0.88 13.5 63 0.88 14.9 Novo Nordisk 29 29 691 0.91 13.4 63 0.91 14.6
30 30 679 0.86 16.6 59 0.83 3.9 Cadila 30 30 657 0.86 16.7 57 0.83 4.3
31 32 600 0.76 6.5 54 0.75 3.3 Indoco Remedies 32 33 563 0.74 6.7 50 0.73 3.2
32 31 579 0.73 11.2 55 0.76 6.9 Franco 33 31 558 0.73 10.6 53 0.76 6.7
33 33 575 0.73 21.0 52 0.73 8.1 Eris 31 32 572 0.75 20.8 52 0.76 8.2
34 36 503 0.64 17.1 43 0.60 12.2 MSD 34 36 501 0.66 16.6 42 0.61 10.8
35 34 481 0.61 5.6 44 0.62 8.1 Himalaya 35 34 479 0.63 5.4 44 0.64 8.3
36 35 466 0.59 7.4 44 0.62 5.3 Merck 36 35 455 0.60 6.3 43 0.62 5.4
37 38 429 0.54 1.9 39 0.55 3.6 Blue Cross 39 39 394 0.52 3.3 36 0.52 3.0
38 37 419 0.53 11.7 42 0.58 18.9 JB Chemicals 38 37 403 0.53 11.7 40 0.58 19.3
39 49 413 0.52 7.3 30 0.42 -20.0 Astrazeneca 37 48 409 0.54 6.7 30 0.43 -20.0
40 43 381 0.48 -11.3 33 0.46 2.0 Bharat Serums 40 42 374 0.49 -11.6 33 0.47 1.7
41 40 381 0.48 23.0 36 0.51 17.5 Meyer Organics 42 40 369 0.49 22.8 35 0.51 17.5
42 39 379 0.48 -0.4 37 0.52 1.9 Raptakos, Brett 41 38 374 0.49 -0.6 37 0.54 1.8
43 47 351 0.44 10.4 31 0.43 3.4 Hetero 47 51 319 0.42 10.8 28 0.41 3.6
44 42 343 0.43 12.9 34 0.47 5.1 Medley 46 43 325 0.43 13.6 32 0.47 5.2
45 41 342 0.43 39.5 34 0.48 49.0 Akumentis 43 41 335 0.44 41.1 34 0.49 49.6
46 44 334 0.42 8.8 31 0.44 6.9 Janssen 44 44 334 0.44 8.8 31 0.45 6.8
47 45 333 0.42 9.3 31 0.44 5.5 Wallace 48 46 309 0.41 16.0 30 0.44 17.5
48 50 333 0.42 1.0 30 0.42 4.1 Win-Medicare 45 49 328 0.43 -0.4 29 0.43 2.8
49 57 316 0.40 6.2 24 0.34 -14.2 Fourrts 49 57 302 0.40 5.3 23 0.34 -15.4
50 46 303 0.38 6.5 31 0.43 9.8 Albert David 52 45 297 0.39 6.4 30 0.44 9.8
With Bonus Units at Full Value Without Bonus Units
Rank MAT July -14 Jul-14 Val in Crs Rank MAT July -14 Jul-14
MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% CORPORATE MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR%
78902 100 6.4 7161 100 7.2 IPM 75955 100 6.6 6897 100 7.6
1 1 4933 6.25 3.2 443 6.19 5.4 Abbott + Abbott HC + Novo 1 1 4837 6.37 3.1 435 6.31 5.8
2 2 4269 5.41 15.7 387 5.41 14.4 Sun Pharma 2 2 4174 5.50 14.9 381 5.52 14.8
3 3 3867 4.90 5.9 344 4.81 9.5 Cipla 3 3 3637 4.79 8.6 324 4.70 11.2
4 4 3397 4.30 5.8 295 4.12 5.6 Zydus + Biochem 4 4 3174 4.18 5.5 277 4.01 5.8
5 6 3055 3.87 1.8 266 3.72 5.7 Ranbaxy 5 5 2954 3.89 1.8 257 3.73 5.5
6 5 2790 3.54 4.9 272 3.80 9.1 Mankind 9 8 2373 3.12 6.6 236 3.42 12.4
7 9 2761 3.50 -16.4 244 3.40 -9.5 Glaxo 6 7 2734 3.60 -15.5 242 3.51 -8.4
8 8 2698 3.42 7.2 248 3.46 1.0 Alkem + Cachet + Indchemie 8 9 2513 3.31 7.6 232 3.36 1.9
9 7 2649 3.36 12.3 249 3.47 13.2 Lupin 7 6 2593 3.41 12.3 244 3.53 13.6
10 11 2289 2.90 4.1 200 2.80 1.4 Pfizer + Wyeth 10 11 2238 2.95 4.4 196 2.85 1.7
11 12 2183 2.77 12.7 192 2.68 5.4 Emcure + Zuventus 11 12 2118 2.79 13.1 187 2.71 5.5
12 10 2152 2.73 14.8 223 3.11 27.9 Macleods 13 10 2016 2.65 14.6 209 3.03 28.1
13 14 2043 2.59 14.4 185 2.59 12.9 Intas 12 13 2017 2.65 14.7 183 2.66 13.2
14 15 1956 2.48 -1.9 178 2.49 4.0 Sanofi India + Universal 14 14 1918 2.53 -2.1 175 2.53 3.9
15 13 1928 2.44 14.3 188 2.63 16.2 Aristo 16 16 1695 2.23 11.9 164 2.38 15.3
16 16 1744 2.21 3.0 169 2.36 12.6 Torrent 15 15 1709 2.25 3.4 165 2.40 13.0
17 18 1702 2.16 15.8 150 2.10 9.6 Glenmark 17 18 1652 2.18 15.5 146 2.11 9.3
18 17 1679 2.13 7.2 154 2.15 11.9 Dr. Reddys 18 17 1644 2.16 6.4 150 2.18 11.6
19 19 1606 2.04 11.0 148 2.06 12.4 Micro + Bal 19 19 1537 2.02 11.6 141 2.05 13.0
20 20 1420 1.80 21.8 133 1.85 21.2 Ipca 21 20 1353 1.78 21.9 127 1.84 22.4
21 21 1419 1.80 8.4 126 1.76 8.2 USV 20 21 1412 1.86 8.3 126 1.82 8.2
22 22 1237 1.57 5.6 103 1.43 7.9 Wockhardt 22 22 1213 1.60 5.5 101 1.46 8.1
23 23 1129 1.43 -2.5 99 1.38 -2.5 Novartis 23 23 1091 1.44 -1.5 96 1.39 -0.9
24 24 1066 1.35 9.1 92 1.29 4.7 Alembic 24 24 1035 1.36 9.8 90 1.30 5.7
25 25 820 1.04 2.5 74 1.04 0.5 FDC 25 25 797 1.05 2.3 72 1.04 0.2
26 26 798 1.01 8.3 72 1.00 13.1 Unichem 26 26 781 1.03 7.7 70 1.02 13.1
27 27 784 0.99 11.4 67 0.93 6.9 MSD + Fulford + Organon 27 27 773 1.02 11.1 66 0.95 6.2
28 28 679 0.86 16.6 59 0.83 3.9 Cadila 28 28 657 0.86 16.7 57 0.83 4.3
29 30 600 0.76 6.5 54 0.75 3.3 Indoco Remedies 30 31 563 0.74 6.7 50 0.73 3.2
30 29 579 0.73 11.2 55 0.76 6.9 Franco 31 29 558 0.73 10.6 53 0.76 6.7
31 31 575 0.73 21.0 52 0.73 8.1 Eris 29 30 572 0.75 20.8 52 0.76 8.2
32 32 481 0.61 5.6 44 0.62 8.1 Himalaya 32 32 479 0.63 5.4 44 0.64 8.3
33 33 466 0.59 7.4 44 0.62 5.3 Merck 33 33 455 0.60 6.3 43 0.62 5.4
34 35 429 0.54 1.9 39 0.55 3.6 Blue Cross 36 36 394 0.52 3.3 36 0.52 3.0
35 34 419 0.53 11.7 42 0.58 18.9 JB Chemicals 35 34 403 0.53 11.7 40 0.58 19.3
36 46 413 0.52 7.3 30 0.42 -20.0 Astrazeneca 34 45 409 0.54 6.7 30 0.43 -20.0
37 41 381 0.48 -11.3 33 0.46 2.0 Bharat Serums 37 40 374 0.49 -11.6 33 0.47 1.7
38 37 381 0.48 23.0 36 0.51 17.5 Meyer Organics 39 37 369 0.49 22.8 35 0.51 17.5
39 36 379 0.48 -0.4 37 0.52 1.9 Raptakos, Brett 38 35 374 0.49 -0.6 37 0.54 1.8
40 39 367 0.46 8.2 34 0.48 4.8 Wallace + Indi Pharma 40 39 343 0.45 14.0 33 0.48 15.3
41 44 351 0.44 10.4 31 0.43 3.4 Hetero 45 48 319 0.42 10.8 28 0.41 3.6
42 40 343 0.43 12.9 34 0.47 5.1 Medley 44 41 325 0.43 13.6 32 0.47 5.2
43 38 342 0.43 39.5 34 0.48 49.0 Akumentis 41 38 335 0.44 41.1 34 0.49 49.6
44 42 334 0.42 8.8 31 0.44 6.9 Janssen 42 42 334 0.44 8.8 31 0.45 6.8
45 47 333 0.42 1.0 30 0.42 4.1 Win-Medicare 43 46 328 0.43 -0.4 29 0.43 2.8
46 53 316 0.40 6.2 24 0.34 -14.2 Fourrts 46 54 302 0.40 5.3 23 0.34 -15.4
47 43 303 0.38 6.5 31 0.43 9.8 Albert David 49 43 297 0.39 6.4 30 0.44 9.8
48 48 302 0.38 37.7 29 0.40 41.2 Ajanta 47 47 300 0.40 37.5 29 0.41 41.0
49 52 301 0.38 46.3 26 0.36 27.6 Biocon 48 52 300 0.39 46.3 26 0.38 27.5
50 45 286 0.36 23.3 31 0.43 40.9 Apex Lab 52 44 277 0.37 23.0 30 0.43 41.4

More Related Content

Viewers also liked

Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACSIndian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACSAnup Soans
 
India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015QuintilesIMS Asia Pacific
 
Demonetization - Impact on Indian Pharma
Demonetization - Impact on Indian PharmaDemonetization - Impact on Indian Pharma
Demonetization - Impact on Indian PharmaAnup Soans
 
Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?Anup Soans
 
Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015Anup Soans
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 
Mastering the student first approach to marketing automation webinar
Mastering the student first approach to marketing automation webinarMastering the student first approach to marketing automation webinar
Mastering the student first approach to marketing automation webinarfathomseo
 
S. M. Mehta & Associates - Profile
S. M. Mehta & Associates - ProfileS. M. Mehta & Associates - Profile
S. M. Mehta & Associates - ProfileSAMIR MEHTA
 
Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx
Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptxTorrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx
Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptxSushain Raizada
 
Bli.it la-convalida [presentazione]
Bli.it la-convalida [presentazione]Bli.it la-convalida [presentazione]
Bli.it la-convalida [presentazione]BLI.IT
 
Efs Consultants (India) Pvt
Efs Consultants (India) PvtEfs Consultants (India) Pvt
Efs Consultants (India) Pvtefsconsultants
 
Sectorifics_IIMA_Pharma
Sectorifics_IIMA_PharmaSectorifics_IIMA_Pharma
Sectorifics_IIMA_PharmaAkshay Gautam
 
Pfizer strategy for internationalization
Pfizer strategy for internationalizationPfizer strategy for internationalization
Pfizer strategy for internationalizationAamir chouhan
 
Pfizer-Strategic Management Case
Pfizer-Strategic Management CasePfizer-Strategic Management Case
Pfizer-Strategic Management CaseSanjaya Sanjaya
 
Project on bajaj Auto Ltd
Project on bajaj Auto LtdProject on bajaj Auto Ltd
Project on bajaj Auto LtdSunil Jaiswal
 
September_08 SQuAd Presentation
September_08 SQuAd PresentationSeptember_08 SQuAd Presentation
September_08 SQuAd Presentationiradari
 
Thesis writing assignment; thesis presentation
Thesis writing assignment; thesis presentationThesis writing assignment; thesis presentation
Thesis writing assignment; thesis presentationtykl94
 
Proof of stock reduction
Proof of stock reduction Proof of stock reduction
Proof of stock reduction Ghassan Kabbara
 

Viewers also liked (20)

Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACSIndian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
 
India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015
 
Demonetization - Impact on Indian Pharma
Demonetization - Impact on Indian PharmaDemonetization - Impact on Indian Pharma
Demonetization - Impact on Indian Pharma
 
Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?
 
Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 
Mastering the student first approach to marketing automation webinar
Mastering the student first approach to marketing automation webinarMastering the student first approach to marketing automation webinar
Mastering the student first approach to marketing automation webinar
 
S. M. Mehta & Associates - Profile
S. M. Mehta & Associates - ProfileS. M. Mehta & Associates - Profile
S. M. Mehta & Associates - Profile
 
Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx
Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptxTorrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx
Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx
 
Bli.it la-convalida [presentazione]
Bli.it la-convalida [presentazione]Bli.it la-convalida [presentazione]
Bli.it la-convalida [presentazione]
 
Efs Consultants (India) Pvt
Efs Consultants (India) PvtEfs Consultants (India) Pvt
Efs Consultants (India) Pvt
 
Novartis india
Novartis indiaNovartis india
Novartis india
 
Sectorifics_IIMA_Pharma
Sectorifics_IIMA_PharmaSectorifics_IIMA_Pharma
Sectorifics_IIMA_Pharma
 
Pfizer strategy for internationalization
Pfizer strategy for internationalizationPfizer strategy for internationalization
Pfizer strategy for internationalization
 
Pfizer-Strategic Management Case
Pfizer-Strategic Management CasePfizer-Strategic Management Case
Pfizer-Strategic Management Case
 
Project on bajaj Auto Ltd
Project on bajaj Auto LtdProject on bajaj Auto Ltd
Project on bajaj Auto Ltd
 
September_08 SQuAd Presentation
September_08 SQuAd PresentationSeptember_08 SQuAd Presentation
September_08 SQuAd Presentation
 
Thesis writing assignment; thesis presentation
Thesis writing assignment; thesis presentationThesis writing assignment; thesis presentation
Thesis writing assignment; thesis presentation
 
S L Salon P P T
S L Salon P P TS L Salon P P T
S L Salon P P T
 
Proof of stock reduction
Proof of stock reduction Proof of stock reduction
Proof of stock reduction
 

More from Anup Soans

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...Anup Soans
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardAnup Soans
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingAnup Soans
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thAnup Soans
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMAnup Soans
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021Anup Soans
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsAnup Soans
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentAnup Soans
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramAnup Soans
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramAnup Soans
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsAnup Soans
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow Anup Soans
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectAnup Soans
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramAnup Soans
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsAnup Soans
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollAnup Soans
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceAnup Soans
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Anup Soans
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 IssueAnup Soans
 

More from Anup Soans (20)

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
 

Indian Pharma Market Top 50 Highlights

  • 1. With Bonus Units at Full Value Without Bonus Units Rank MAT July -14 Jul-14 Val in Crs Rank MAT July -14 Jul-14 MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% COMPANY MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% 78902 100 6.4 7161 100 7.2 IPM 75955 100 6.6 6897 100 7.6 1 1 4269 5.41 15.7 387 5.41 14.4 Sun Pharma 1 1 4174 5.50 14.9 381 5.52 14.8 2 2 3867 4.90 5.9 344 4.81 9.5 Cipla 2 2 3637 4.79 8.6 324 4.70 11.2 3 4 3097 3.93 5.3 269 3.75 6.3 Zydus Cadila 4 4 2908 3.83 5.2 254 3.68 6.5 4 5 3055 3.87 1.8 266 3.72 5.7 Ranbaxy 3 3 2954 3.89 1.8 257 3.73 5.5 5 3 2790 3.54 4.9 272 3.80 9.1 Mankind 8 7 2373 3.12 6.6 236 3.42 12.4 6 7 2761 3.50 -16.4 244 3.40 -9.5 Glaxo 5 6 2734 3.60 -15.5 242 3.51 -8.4 7 8 2689 3.41 -2.2 231 3.23 -4.0 Abbott HC 6 8 2605 3.43 -2.4 224 3.25 -3.5 8 6 2649 3.36 12.3 249 3.47 13.2 Lupin 7 5 2593 3.41 12.3 244 3.53 13.6 9 10 2411 3.06 7.2 220 3.08 0.3 Alkem 9 10 2247 2.96 7.7 206 2.98 1.2 10 11 2289 2.90 4.1 200 2.80 1.4 Pfizer 10 11 2238 2.95 4.4 196 2.85 1.7 11 9 2152 2.73 14.8 223 3.11 27.9 Macleods 12 9 2016 2.65 14.6 209 3.03 28.1 12 13 2043 2.59 14.4 185 2.59 12.9 Intas 11 12 2017 2.65 14.7 183 2.66 13.2 13 14 1956 2.48 -1.9 178 2.49 4.0 Sanofi India 13 13 1918 2.53 -2.1 175 2.53 3.9 14 12 1928 2.44 14.3 188 2.63 16.2 Aristo 15 15 1695 2.23 11.9 164 2.38 15.3 15 15 1744 2.21 3.0 169 2.36 12.6 Torrent 14 14 1709 2.25 3.4 165 2.40 13.0 16 17 1702 2.16 15.8 150 2.10 9.6 Glenmark 16 18 1652 2.18 15.5 146 2.11 9.3 17 16 1679 2.13 7.2 154 2.15 11.9 Dr. Reddys 17 16 1644 2.16 6.4 150 2.18 11.6 18 19 1574 1.99 11.1 145 2.03 13.0 Micro Lab 19 19 1505 1.98 11.8 139 2.01 13.6 19 18 1551 1.97 9.3 149 2.08 19.4 Abbott 18 17 1540 2.03 9.0 148 2.14 19.4 20 20 1420 1.80 21.8 133 1.85 21.2 Ipca 21 20 1353 1.78 21.9 127 1.84 22.4 21 21 1419 1.80 8.4 126 1.76 8.2 USV 20 21 1412 1.86 8.3 126 1.82 8.2 22 22 1362 1.73 21.6 124 1.73 17.5 Emcure 22 22 1334 1.76 21.7 122 1.76 17.3 23 23 1237 1.57 5.6 103 1.43 7.9 Wockhardt 23 23 1213 1.60 5.5 101 1.46 8.1 24 24 1129 1.43 -2.5 99 1.38 -2.5 Novartis 24 24 1091 1.44 -1.5 96 1.39 -0.9 25 25 1066 1.35 9.1 92 1.29 4.7 Alembic 25 25 1035 1.36 9.8 90 1.30 5.7 26 28 822 1.04 0.6 68 0.95 -11.1 Zuventus 27 28 784 1.03 0.8 65 0.95 -11.2 27 26 820 1.04 2.5 74 1.04 0.5 FDC 26 26 797 1.05 2.3 72 1.04 0.2 28 27 798 1.01 8.3 72 1.00 13.1 Unichem 28 27 781 1.03 7.7 70 1.02 13.1 29 29 693 0.88 13.5 63 0.88 14.9 Novo Nordisk 29 29 691 0.91 13.4 63 0.91 14.6 30 30 679 0.86 16.6 59 0.83 3.9 Cadila 30 30 657 0.86 16.7 57 0.83 4.3 31 32 600 0.76 6.5 54 0.75 3.3 Indoco Remedies 32 33 563 0.74 6.7 50 0.73 3.2
  • 2. 32 31 579 0.73 11.2 55 0.76 6.9 Franco 33 31 558 0.73 10.6 53 0.76 6.7 33 33 575 0.73 21.0 52 0.73 8.1 Eris 31 32 572 0.75 20.8 52 0.76 8.2 34 36 503 0.64 17.1 43 0.60 12.2 MSD 34 36 501 0.66 16.6 42 0.61 10.8 35 34 481 0.61 5.6 44 0.62 8.1 Himalaya 35 34 479 0.63 5.4 44 0.64 8.3 36 35 466 0.59 7.4 44 0.62 5.3 Merck 36 35 455 0.60 6.3 43 0.62 5.4 37 38 429 0.54 1.9 39 0.55 3.6 Blue Cross 39 39 394 0.52 3.3 36 0.52 3.0 38 37 419 0.53 11.7 42 0.58 18.9 JB Chemicals 38 37 403 0.53 11.7 40 0.58 19.3 39 49 413 0.52 7.3 30 0.42 -20.0 Astrazeneca 37 48 409 0.54 6.7 30 0.43 -20.0 40 43 381 0.48 -11.3 33 0.46 2.0 Bharat Serums 40 42 374 0.49 -11.6 33 0.47 1.7 41 40 381 0.48 23.0 36 0.51 17.5 Meyer Organics 42 40 369 0.49 22.8 35 0.51 17.5 42 39 379 0.48 -0.4 37 0.52 1.9 Raptakos, Brett 41 38 374 0.49 -0.6 37 0.54 1.8 43 47 351 0.44 10.4 31 0.43 3.4 Hetero 47 51 319 0.42 10.8 28 0.41 3.6 44 42 343 0.43 12.9 34 0.47 5.1 Medley 46 43 325 0.43 13.6 32 0.47 5.2 45 41 342 0.43 39.5 34 0.48 49.0 Akumentis 43 41 335 0.44 41.1 34 0.49 49.6 46 44 334 0.42 8.8 31 0.44 6.9 Janssen 44 44 334 0.44 8.8 31 0.45 6.8 47 45 333 0.42 9.3 31 0.44 5.5 Wallace 48 46 309 0.41 16.0 30 0.44 17.5 48 50 333 0.42 1.0 30 0.42 4.1 Win-Medicare 45 49 328 0.43 -0.4 29 0.43 2.8 49 57 316 0.40 6.2 24 0.34 -14.2 Fourrts 49 57 302 0.40 5.3 23 0.34 -15.4 50 46 303 0.38 6.5 31 0.43 9.8 Albert David 52 45 297 0.39 6.4 30 0.44 9.8
  • 3. With Bonus Units at Full Value Without Bonus Units Rank MAT July -14 Jul-14 Val in Crs Rank MAT July -14 Jul-14 MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% CORPORATE MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% 78902 100 6.4 7161 100 7.2 IPM 75955 100 6.6 6897 100 7.6 1 1 4933 6.25 3.2 443 6.19 5.4 Abbott + Abbott HC + Novo 1 1 4837 6.37 3.1 435 6.31 5.8 2 2 4269 5.41 15.7 387 5.41 14.4 Sun Pharma 2 2 4174 5.50 14.9 381 5.52 14.8 3 3 3867 4.90 5.9 344 4.81 9.5 Cipla 3 3 3637 4.79 8.6 324 4.70 11.2 4 4 3397 4.30 5.8 295 4.12 5.6 Zydus + Biochem 4 4 3174 4.18 5.5 277 4.01 5.8 5 6 3055 3.87 1.8 266 3.72 5.7 Ranbaxy 5 5 2954 3.89 1.8 257 3.73 5.5 6 5 2790 3.54 4.9 272 3.80 9.1 Mankind 9 8 2373 3.12 6.6 236 3.42 12.4 7 9 2761 3.50 -16.4 244 3.40 -9.5 Glaxo 6 7 2734 3.60 -15.5 242 3.51 -8.4 8 8 2698 3.42 7.2 248 3.46 1.0 Alkem + Cachet + Indchemie 8 9 2513 3.31 7.6 232 3.36 1.9 9 7 2649 3.36 12.3 249 3.47 13.2 Lupin 7 6 2593 3.41 12.3 244 3.53 13.6 10 11 2289 2.90 4.1 200 2.80 1.4 Pfizer + Wyeth 10 11 2238 2.95 4.4 196 2.85 1.7 11 12 2183 2.77 12.7 192 2.68 5.4 Emcure + Zuventus 11 12 2118 2.79 13.1 187 2.71 5.5 12 10 2152 2.73 14.8 223 3.11 27.9 Macleods 13 10 2016 2.65 14.6 209 3.03 28.1 13 14 2043 2.59 14.4 185 2.59 12.9 Intas 12 13 2017 2.65 14.7 183 2.66 13.2 14 15 1956 2.48 -1.9 178 2.49 4.0 Sanofi India + Universal 14 14 1918 2.53 -2.1 175 2.53 3.9 15 13 1928 2.44 14.3 188 2.63 16.2 Aristo 16 16 1695 2.23 11.9 164 2.38 15.3 16 16 1744 2.21 3.0 169 2.36 12.6 Torrent 15 15 1709 2.25 3.4 165 2.40 13.0 17 18 1702 2.16 15.8 150 2.10 9.6 Glenmark 17 18 1652 2.18 15.5 146 2.11 9.3 18 17 1679 2.13 7.2 154 2.15 11.9 Dr. Reddys 18 17 1644 2.16 6.4 150 2.18 11.6 19 19 1606 2.04 11.0 148 2.06 12.4 Micro + Bal 19 19 1537 2.02 11.6 141 2.05 13.0 20 20 1420 1.80 21.8 133 1.85 21.2 Ipca 21 20 1353 1.78 21.9 127 1.84 22.4 21 21 1419 1.80 8.4 126 1.76 8.2 USV 20 21 1412 1.86 8.3 126 1.82 8.2 22 22 1237 1.57 5.6 103 1.43 7.9 Wockhardt 22 22 1213 1.60 5.5 101 1.46 8.1 23 23 1129 1.43 -2.5 99 1.38 -2.5 Novartis 23 23 1091 1.44 -1.5 96 1.39 -0.9 24 24 1066 1.35 9.1 92 1.29 4.7 Alembic 24 24 1035 1.36 9.8 90 1.30 5.7 25 25 820 1.04 2.5 74 1.04 0.5 FDC 25 25 797 1.05 2.3 72 1.04 0.2 26 26 798 1.01 8.3 72 1.00 13.1 Unichem 26 26 781 1.03 7.7 70 1.02 13.1 27 27 784 0.99 11.4 67 0.93 6.9 MSD + Fulford + Organon 27 27 773 1.02 11.1 66 0.95 6.2 28 28 679 0.86 16.6 59 0.83 3.9 Cadila 28 28 657 0.86 16.7 57 0.83 4.3 29 30 600 0.76 6.5 54 0.75 3.3 Indoco Remedies 30 31 563 0.74 6.7 50 0.73 3.2 30 29 579 0.73 11.2 55 0.76 6.9 Franco 31 29 558 0.73 10.6 53 0.76 6.7 31 31 575 0.73 21.0 52 0.73 8.1 Eris 29 30 572 0.75 20.8 52 0.76 8.2
  • 4. 32 32 481 0.61 5.6 44 0.62 8.1 Himalaya 32 32 479 0.63 5.4 44 0.64 8.3 33 33 466 0.59 7.4 44 0.62 5.3 Merck 33 33 455 0.60 6.3 43 0.62 5.4 34 35 429 0.54 1.9 39 0.55 3.6 Blue Cross 36 36 394 0.52 3.3 36 0.52 3.0 35 34 419 0.53 11.7 42 0.58 18.9 JB Chemicals 35 34 403 0.53 11.7 40 0.58 19.3 36 46 413 0.52 7.3 30 0.42 -20.0 Astrazeneca 34 45 409 0.54 6.7 30 0.43 -20.0 37 41 381 0.48 -11.3 33 0.46 2.0 Bharat Serums 37 40 374 0.49 -11.6 33 0.47 1.7 38 37 381 0.48 23.0 36 0.51 17.5 Meyer Organics 39 37 369 0.49 22.8 35 0.51 17.5 39 36 379 0.48 -0.4 37 0.52 1.9 Raptakos, Brett 38 35 374 0.49 -0.6 37 0.54 1.8 40 39 367 0.46 8.2 34 0.48 4.8 Wallace + Indi Pharma 40 39 343 0.45 14.0 33 0.48 15.3 41 44 351 0.44 10.4 31 0.43 3.4 Hetero 45 48 319 0.42 10.8 28 0.41 3.6 42 40 343 0.43 12.9 34 0.47 5.1 Medley 44 41 325 0.43 13.6 32 0.47 5.2 43 38 342 0.43 39.5 34 0.48 49.0 Akumentis 41 38 335 0.44 41.1 34 0.49 49.6 44 42 334 0.42 8.8 31 0.44 6.9 Janssen 42 42 334 0.44 8.8 31 0.45 6.8 45 47 333 0.42 1.0 30 0.42 4.1 Win-Medicare 43 46 328 0.43 -0.4 29 0.43 2.8 46 53 316 0.40 6.2 24 0.34 -14.2 Fourrts 46 54 302 0.40 5.3 23 0.34 -15.4 47 43 303 0.38 6.5 31 0.43 9.8 Albert David 49 43 297 0.39 6.4 30 0.44 9.8 48 48 302 0.38 37.7 29 0.40 41.2 Ajanta 47 47 300 0.40 37.5 29 0.41 41.0 49 52 301 0.38 46.3 26 0.36 27.6 Biocon 48 52 300 0.39 46.3 26 0.38 27.5 50 45 286 0.36 23.3 31 0.43 40.9 Apex Lab 52 44 277 0.37 23.0 30 0.43 41.4